To Investigate the Efficacy and Safety of OPC-6535 in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT00917150 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

771

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: tetomilast (OPC-6535)
DRUG: tetomilast (OPC-6535)
DRUG: tetomilast (OPC-6535)
DRUG: placebo

Sponsor

Otsuka Pharmaceutical Co., Ltd.